C	O
/	O
EBPbeta	O
is	O
over	O
-	O
expressed	O
in	O
gastric	B-Organ
carcinogenesis	O
and	O
is	O
associated	O
with	O
COX	O
-	O
2	O
expression	O
.	O

The	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
beta	O
(	O
C	O
/	O
EBPbeta	O
)	O
transcription	O
factor	O
has	O
been	O
associated	O
with	O
several	O
cancer	B-Cancer
models	O
.	O

In	O
this	O
study	O
,	O
the	O
expression	O
of	O
C	O
/	O
EBPbeta	O
was	O
analysed	O
in	O
a	O
series	O
of	O
90	O
gastric	B-Cancer
carcinomas	I-Cancer
(	O
GCs	B-Cancer
)	O
.	O

We	O
also	O
assessed	O
the	O
effect	O
of	O
C	O
/	O
EBPbeta	O
on	O
COX	O
-	O
2	O
expression	O
.	O

In	O
normal	O
gastric	B-Multi-tissue_structure
mucosa	I-Multi-tissue_structure
,	O
C	O
/	O
EBPbeta	O
expression	O
was	O
restricted	O
to	O
cells	B-Cell
in	O
the	O
proliferative	O
zone	B-Cell
.	O

In	O
intestinal	B-Pathological_formation
metaplasia	I-Pathological_formation
,	O
dysplasia	B-Pathological_formation
,	O
and	O
GC	B-Cancer
of	O
the	O
intestinal	B-Multi-tissue_structure
and	O
atypical	O
subtypes	O
,	O
C	O
/	O
EBPbeta	O
was	O
over	O
-	O
expressed	O
(	O
p	O
<	O
0	O
.	O
0001	O
,	O
for	O
the	O
association	O
with	O
histological	O
type	O
)	O
.	O

C	O
/	O
EBPbeta	O
and	O
Ki67	O
,	O
a	O
marker	O
of	O
cell	B-Cell
proliferation	O
,	O
were	O
also	O
co	O
-	O
expressed	O
in	O
primary	B-Cancer
GC	I-Cancer
.	O

We	O
also	O
observed	O
an	O
overlap	O
between	O
C	O
/	O
EBPbeta	O
and	O
COX	O
-	O
2	O
expression	O
in	O
GC	B-Cancer
.	O

Using	O
GC	B-Cell
cell	I-Cell
lines	I-Cell
we	O
show	O
that	O
C	O
/	O
EBPbeta	O
can	O
regulate	O
the	O
expression	O
of	O
endogenous	O
COX	O
-	O
2	O
and	O
transactivate	O
the	O
promoter	O
of	O
the	O
COX	O
-	O
2	O
gene	O
,	O
depending	O
on	O
its	O
methylation	O
status	O
.	O

These	O
results	O
suggest	O
that	O
C	O
/	O
EBPbeta	O
may	O
be	O
a	O
marker	O
of	O
neoplastic	B-Cancer
transformation	O
and	O
also	O
play	O
an	O
active	O
role	O
in	O
gastric	B-Organ
tumourigenesis	O
by	O
regulating	O
COX	O
-	O
2	O
expression	O
.	O

